Today: 2 May 2026
Cisco stock today: CSCO slips in late-morning trade as tech pressure lingers ahead of Fed minutes
30 December 2025
1 min read

Cisco stock today: CSCO slips in late-morning trade as tech pressure lingers ahead of Fed minutes

NEW YORK, December 30, 2025, 11:31 ET — Regular session

  • Cisco shares were down about 0.5% in late-morning trade, underperforming a little-changed broader market.
  • Traders pointed to thin, year-end liquidity and a second day of pressure in parts of U.S. tech.
  • Investors are watching the Federal Reserve’s December meeting minutes and Cisco’s Jan. 2 ex-dividend date.

Cisco Systems, Inc. shares dipped on Tuesday, tracking a cautious turn in large-cap tech and year-end repositioning with Federal Reserve minutes due later in the day.

The move matters because liquidity is thinner than normal in the holiday-shortened week, which can amplify small shifts in sentiment. U.S. markets are closed on Thursday for New Year’s Day, leaving investors a narrow window to adjust portfolios before 2026.

Cisco’s modest decline also comes a day after U.S. stocks ended lower as heavyweight technology names retreated from last week’s record-high levels in the S&P 500. Traders have been weighing whether the pullback is profit-taking into year-end or the start of a broader rotation.

At 11:31 a.m. ET, Cisco was down 0.46% at $77.44, after trading between $77.17 and $77.90. The stock had slipped about 36 cents from Monday’s close, with roughly 2.1 million shares traded.

The broader tape was steady: the SPDR S&P 500 ETF was little changed and the Invesco QQQ Trust, a proxy for the Nasdaq 100, was fractionally higher. That left Cisco slightly lagging the market’s drift.

“Heading into the new year, you may have some repositioning… I wouldn’t try to make too much out of anything that happens in a holiday-shortened week,” said Art Hogan, chief market strategist at B Riley Wealth, pointing to very light volumes. Reuters

In the absence of a fresh company catalyst, Cisco has tended to trade with broader views on enterprise IT spending and the pace of investment tied to artificial intelligence infrastructure. Cisco raised its fiscal 2026 outlook in November, citing AI-driven demand for networking equipment.

Income-focused investors also have a near-term calendar marker. Cisco said it declared a quarterly dividend of $0.41 per share payable on Jan. 21, 2026, to stockholders of record as of Jan. 2.

Nasdaq lists Jan. 2 as Cisco’s ex-dividend date — the day the stock starts trading without the right to receive the upcoming payout.

Peer moves in networking and data-center hardware were mixed. Arista Networks fell about 0.7%, while Dell Technologies rose about 0.6% and Hewlett Packard Enterprise was flat, underscoring the stock-by-stock nature of late-December trading.

What comes next for Cisco in the near term is less about company headlines and more about the macro tape. Investors are focused on the Fed’s December 9–10 meeting minutes and weekly jobless claims in an otherwise data-light week, after Monday’s tech-led slide.

For traders, Tuesday’s early range set practical levels to watch. Cisco’s session low near $77.17 has been the first downside marker, while a push back toward the day’s $77.90 high would signal a steadier tone in tech into the final sessions of 2025.

Stock Market Today

  • Diageo Shares Seen 25% Undervalued Amid Recent Weakness
    May 2, 2026, 2:02 PM EDT. Diageo (LSE:DGE) shares dropped 27.5% over the past year but rebounded 6.2% in the last month, drawing fresh investor focus. The drinks giant trades at £14.81, roughly 25% below a fair value estimate of £19.81, according to valuation models. The stock's current price/earnings (P/E) ratio is 18.6, above peer averages near 17, while the fair P/E is projected at 22.9. Diageo is targeting growth through premium products, category expansion-especially tequila and ready-to-drink options-and tailored marketing across Europe, Asia-Pacific, and Africa. These efforts aim to tap rising consumer affluence and demographic shifts. However, risks remain from increasing alcohol moderation trends and volatility in emerging markets, potentially impacting revenue and margins. Investors are weighing if the valuation gap signals opportunity or a cautionary sign under shifting market sentiment.

Latest article

Cloudflare’s AI Bet Just Got Bigger Before Earnings. Investors Have One Question

Cloudflare’s AI Bet Just Got Bigger Before Earnings. Investors Have One Question

2 May 2026
Cloudflare shares jumped 6.1% to $217.50 on Friday after the company launched Dynamic Workflows, a new developer tool aimed at AI and software platforms. The release comes days before Cloudflare’s first-quarter earnings report on May 7. Trading volume was just under 3 million shares. Analysts expect Q1 revenue of about $621 million.
Intel Corporation’s SambaNova AI Bet Clears U.S. Review as INTC Stock Nears $100

Intel Corporation’s SambaNova AI Bet Clears U.S. Review as INTC Stock Nears $100

2 May 2026
U.S. antitrust regulators cleared Intel’s investment in SambaNova Systems, granting early termination for the deal and removing a key regulatory barrier. Intel raised its stake in the AI chip startup to 8.2% with a $35 million investment in February and plans another $15 million. The FTC decision does not endorse Intel’s strategy but ends the pre-closing review. Intel shares last closed at $99.62, up 5.44% on AI demand.
Aeluma Stock Jumps Before Q3 Earnings as ALMU Investors Eye May 13 Test

Aeluma Stock Jumps Before Q3 Earnings as ALMU Investors Eye May 13 Test

2 May 2026
Aeluma shares jumped 9.6% to $25.58 Friday, valuing the company at $457 million ahead of fiscal Q3 results due May 13. A Reuters/Refinitiv preview expects a loss of 4 cents per share. Trading volume reached 2.3 million shares. The company reported $1.3 million in revenue and an $11-cent loss per share in its previous quarter.
Eli Lilly stock dips after report flags China price cuts for Mounjaro
Previous Story

Eli Lilly stock dips after report flags China price cuts for Mounjaro

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX
Next Story

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Go toTop